Media-OutReach Newswire Beyfortus® (nirsevimab) approved in Singapore to protect all infants against RSV disease
Media-OutReach Newswire Aon Study Highlights Strategic Wellbeing Imperatives for Chinese Insurers to Build Capability and Address Medical Inflation Costs